Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis

Blood (2023) 141 (25): 3078–3090.

https://doi.org/10.1182/blood.2022015830

Published: 2023

Includes: Supplemental data

Journal Articles

Oncofetal Protein SALL4 Is Highly Expressed in Myelodysplastic Syndrome Alongside with NAT10 and P53

Hiro Tatetsu, MD, Miho Watanabe, MD, Emily F Mason, MD PhD, Scott B Lovitch, MDPhD, Kenji Tokunaga, MD, Eisaku Iwanaga, MD, Masao Matsuoka, MDPhD, Daniel G. Tenen, MD, Li Chai, MD

Blood (2020) 136 (Supplement 1): 34.

https://doi.org/10.1182/blood-2020-134533

Published: 2020

Journal Articles

Lineage-Specific RUNX2 Super-Enhancer Activates MYC Via Translocation (6;8) to Promote the Development of Blastic Plasmacytoid Dendritic Cell Neoplasm

Sho Kubota, PhD, Kenji Tokunaga, MD, Tomohiro Umezu, PhD, Takako Yokomizo, PhD, Motohiko Oshima, PhD, Eisaku Iwanaga, MD PhD, Norio Asou, MDPhD, Atsushi Iwama, MD PhD, Kazuma Ohyashiki, MD PhD, Motomi Osato, MD, PhD, Goro Sashida, MD PhD

Blood (2018) 132 (Supplement 1): 761.

https://doi.org/10.1182/blood-2018-99-110333

Published: 2018

Journal Articles

IDH1 and IDH2 Mutations Confer An Adverse Effect In Patients With Acute Myeloid Leukemia Lacking The NPM1 Mutation

Shunichiro Yamaguchi, MD, Eisaku Iwanaga, MD, PhD, Kenji Tokunaga, MD, Tomoko Nanri, MD, PhD, Taizo Shimomura, MD, PhD, Hitoshi Suzushima, MD, PhD, Yutaka Okuno, MD, PhD, Hiroaki Mitsuya, MD, PhD, Norio Asou, MD, PhD

Blood (2013) 122 (21): 4977.

https://doi.org/10.1182/blood.V122.21.4977.4977

Published: 2013

Journal Articles

Crebbp HAT Domain Mutations Are Frequently Detected in Adult Acute Lymphoblastic Leukemia

Kenji Tokunaga, MD, Shunichiro Yamaguchi, MD, Eisaku Iwanaga, MD, PhD, Tomoko Nanri, MD, PhD, Taizo Shimomura, MD, PhD, Hitoshi Suzushima, MD, PhD, Mitsuya Hiroaki, MD, PhD, Norio Asou, MD, PhD

Blood (2012) 120 (21): 1419.

https://doi.org/10.1182/blood.V120.21.1419.1419

Published: 2012

Journal Articles

Prognostic Impact and Concurrent Genetic Alterations of CEBPA Double Mutations in Adults with Cytogenetically Intermediate-Risk Acute Myeloid Leukemia.

Shunichiro Yamaguchi, MD, Kenji Tokunaga, MD, Eisaku Iwanaga, MD, PhD, Tomoko Nanri, MD, PhD, Taizo Shimomura, MD, PhD, Hitoshi Suzushima, MD, PhD, Hiroaki Mitsuya, Norio Asou, MD, PhD

Blood (2012) 120 (21): 2538.

https://doi.org/10.1182/blood.V120.21.2538.2538

Published: 2012

Journal Articles

IDH2 Mutations Have An Unfavorable Impact in Elderly Patients with Acute Myeloid Leukemia

Shunichro Yamaguchi, MD, Eisaku Iwanaga, MD, Kenji Tokunaga, MD, Tomoko Nanri, MD, PhD, Hitoshi Suzushima, MD, PhD, Taizo Shimomura, MD, PhD, Hiroaki Mitsuya, MD, PhD, Norio Asou, MD, PhD

Blood (2011) 118 (21): 2519.

https://doi.org/10.1182/blood.V118.21.2519.2519

Published: 2011

Journal Articles

Acute Promyelocytic Leukemia Harboring STAT5b-RAR α Fusion Gene and G596V Mutation in the Stat5b SH2 Domain of the Fusion Gene.

Eisaku Iwanaga, Miki Nakamura, Tomoko Nanri, Toshiro Kawakita, Naofumi Matsuno, Koyu Hoshino, Kentaro Horikawa, Hiroaki Mitsuya, Norio Asou

Blood (2007) 110 (11): 4227.

https://doi.org/10.1182/blood.V110.11.4227.4227

Published: 2007

Journal Articles

A JAK2-V617F Activating Mutation in Addition to C-KIT and FLT3 Mutations Is Associated with Clinical Outcome in Patients with t(8;21)(q22;q22;) Acute Myeloid Leukemia.

Tomoko Nanri, MD, PhD, Eisaku Iwanaga, MD, Naofumi Matsuno, MD, PhD, Toshiro Kawakita, MD, Hitoshi Suzushima, MD, PhD, Fumio Kawano, MD, PhD, Hiroaki Mitsuya, MD, PhD, Norio Asou, MD, PhD

Blood (2007) 110 (11): 3492.

https://doi.org/10.1182/blood.V110.11.3492.3492

Published: 2007

Journal Articles

A Pedigree Harboring a Germ-Line N-Terminal C/EBPα Mutation and Development of Acute Myeloblastic Leukemia with a Somatic C-Terminal C/EBPα Mutation.

Tomoko Nanri, MD, Naokuni Uike, MD, Toshiro Kawakita, MD, Eisaku Iwanaga, MD, Koyu Hoshino, MD, Hiroaki Mitsuya, MD, Norio Asou, MD

Blood (2006) 108 (11): 1916.

https://doi.org/10.1182/blood.V108.11.1916.1916

Published: 2006

NARROW

Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis

Oncofetal Protein SALL4 Is Highly Expressed in Myelodysplastic Syndrome Alongside with NAT10 and P53

Lineage-Specific RUNX2 Super-Enhancer Activates MYC Via Translocation (6;8) to Promote the Development of Blastic Plasmacytoid Dendritic Cell Neoplasm

IDH1 and IDH2 Mutations Confer An Adverse Effect In Patients With Acute Myeloid Leukemia Lacking The NPM1 Mutation

Crebbp HAT Domain Mutations Are Frequently Detected in Adult Acute Lymphoblastic Leukemia

Prognostic Impact and Concurrent Genetic Alterations of CEBPA Double Mutations in Adults with Cytogenetically Intermediate-Risk Acute Myeloid Leukemia.

IDH2 Mutations Have An Unfavorable Impact in Elderly Patients with Acute Myeloid Leukemia

Acute Promyelocytic Leukemia Harboring STAT5b-RAR α Fusion Gene and G596V Mutation in the Stat5b SH2 Domain of the Fusion Gene.

A JAK2-V617F Activating Mutation in Addition to C-KIT and FLT3 Mutations Is Associated with Clinical Outcome in Patients with t(8;21)(q22;q22;) Acute Myeloid Leukemia.

A Pedigree Harboring a Germ-Line N-Terminal C/EBPα Mutation and Development of Acute Myeloblastic Leukemia with a Somatic C-Terminal C/EBPα Mutation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only